Sun Pharmaceutical Industries reports 11% rise in Q3 consolidated net profit

01 Feb 2022 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2021.

The company has reported a rise of 10.39% in its net profit at Rs 515.43 crore for the quarter under review as compared to Rs 466.92 crore for the same quarter in the previous year. Total income of the company increased by 4.48% at Rs 4075.89 crore for Q3FY22 as compared Rs 3901.34 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 11.14% in its net profit at Rs 2058.80 crore for the quarter under review as compared to Rs 1852.48 crore for the same quarter in the previous year. Total income of the company increased by 12.50% at Rs 10295.57 crore for Q3FY22 as compared Rs 9151.73 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.